All In MedTech

FDA Clearance Tracker · P030016-S049

Visian® Toric Implantable Collamer® Lens (TICL)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 10, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 10, 2025

Approved

Time to decision

167 days

Received Jun 26, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P030016-S049
Device name
Visian® Toric Implantable Collamer® Lens (TICL)
Applicant location
Monrovia, CA
Received
Jun 26, 2025
Decided
Dec 10, 2025
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P030016

Device type

Device class
Class III
Regulation
21 CFR 886.3600
Specialty
Ophthalmology

Every decision under product code QCB

FDA's approval statement

As written in FDA's record.

Approval for updates to labeling for the Visian® Toric Implantable Collamer Lens (TICL)™, EVO/EVO+ Visian® ICL™, and EVO/EVO+ Visian® TICL™ to reflect the findings of the P030016/S001 PMA New Enrollment Post-Approval Study.

Source documents

Other decisions for STAAR Surgical Company

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

3 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.